Replimune Appoints Dieter K. Weinand to Board of Directors

WOBURN, Massachusetts, June 22, 2018 -- (Healthcare Sales & Marketing Network) -- Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Dieter K. Weinand to its Board as an ind... Biopharmaceuticals, Oncology, Personnel Replimune, oncolytic immunotherapies, Immulytic, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news